First Time Loading...

Pieris Pharmaceuticals Inc
NASDAQ:PIRS

Watchlist Manager
Pieris Pharmaceuticals Inc Logo
Pieris Pharmaceuticals Inc
NASDAQ:PIRS
Watchlist
Price: 11.08 USD -1.42% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

PIRS Price Targets Summary
Pieris Pharmaceuticals Inc

Wall Street analysts forecast PIRS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PIRS is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

PIRS Lowest Forecast
Wall Street Target
7.07 USD
36% Downside
PIRS Average Forecast
Wall Street Target
7.14 USD
36% Downside
PIRS Highest Forecast
Wall Street Target
7.35 USD
34% Downside
Lowest
Price Target
7.07 USD
36% Downside
Average
Price Target
7.14 USD
36% Downside
Highest
Price Target
7.35 USD
34% Downside
Pieris Pharmaceuticals Inc Competitors:
Price Targets
S
688373
Shanghai MicuRx Pharmaceutical Co Ltd
71% Upside
MYGN
Myriad Genetics Inc
25% Upside
ADAG
Adagene Inc
408% Upside
CRIS
Curis Inc
36% Upside
S
688373
Shanghai MicuRx Pharmaceutical Co Ltd
71% Upside
MYGN
Myriad Genetics Inc
25% Upside
ADAG
Adagene Inc
408% Upside
CRIS
Curis Inc
36% Upside
BIIB
Biogen Inc
34% Upside
Y
YS
YS Biopharma Co Ltd
477% Upside
M
MGX
Metagenomi Inc
263% Upside
IOVA
Iovance Biotherapeutics Inc
95% Upside

Revenue
Forecast

Revenue Estimate
Pieris Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Pieris Pharmaceuticals Inc's revenue is 40%.

40%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
31%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pieris Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pieris Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
PIRS intrinsic value, competitors valuation, and company profile.
DCF Valuation
PIRS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PIRS stock valuation using valuation multiples.
Wall Street Estimates
PIRS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PIRS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PIRS's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for PIRS is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.